Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data

This study aimed at producing an updated assessment of the incidence of anaphylaxis associated with COVID-19 vaccines based on pharmacovigilance data. Anaphylactic reaction and anaphylactic shock data post-COVID-19-vaccination reported from week 52, 2020 to week 1 or week 2, 2023 were collected from...

Descripción completa

Detalles Bibliográficos
Autores principales: Boufidou, Fotini, Hatziantoniou, Sophia, Theodoridou, Kalliopi, Maltezou, Helena C., Vasileiou, Konstantinos, Anastassopoulou, Cleo, Medić, Snežana, Tsakris, Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051410/
https://www.ncbi.nlm.nih.gov/pubmed/36992197
http://dx.doi.org/10.3390/vaccines11030613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051410/
https://www.ncbi.nlm.nih.gov/pubmed/36992197
http://dx.doi.org/10.3390/vaccines11030613

Ejemplares similares